A Precision Medicine Approach to Treating Alzheimer’s Disease using Rosiglitazone Therapy: A Biomarker Analysis of the REFLECT Trials

Manuscript Number: 

20-1610R1

Author(s): 
James Hall, Leigh A. Johnson, Sid E. O’Bryant, Melissa Petersen, Robert A. Rissman, Fan Zhang

Disclosures

James Hall

  • Nothing to Disclose

Leigh A. Johnson

  • Nothing to Disclose

Sid E. O’Bryant

  • Equity:
    I am the founding scientist in Cx Precision Medicine which has licensed multiple precision medicine related patents.
    Patents/Royalties
    I have multiple patents on precision medicine approaches to diagnosing and/or treating neurodegenerative diseases.
    Grants
    • Agency: 
      Cx Precision Medicine
      Dates: 
      06/01/2020 - 06/01/2021

Melissa Petersen

  • Nothing to Disclose

Robert A. Rissman

  • Nothing to Disclose

Fan Zhang

  • Nothing to Disclose